TP53 and colorectal cancer: MA induced E2F downregulation in colorectal cancer cells while inducing cell cycle arrest at the G0/G1 phase by lowering the expression of CDK2/4 and cyclin D1 and impacting p53/p21/p27 pathways (Lin et al., 2018).